Does Gestational Thrombocytopenia and Immune Thrombocytopenic Purpura Warrant Hospital Admission?

Ayesha Ellahi; Ayesha Nayyar; Maham Arshad; Wasiullah Khan; Afnan Naeem; Warda Furqan

doi:10.51253/pafmj.v74i2.9192

Authors

Ayesha Ellahi Army Medical College
Ayesha Nayyar Department of Pathology (Haematology). Army Medical College Rawalpindi / National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Maham Arshad Department of Pathology (Haematology). Army Medical College Rawalpindi / National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Wasiullah Khan Department of Pharmacology, Riphah International University Islamabad
Afnan Naeem Department Microbiology, Army Medical College /National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Warda Furqan Department Microbiology, Army Medical College /National University of Medical Sciences (NUMS) Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74i2.9192

Keywords:

Gestational thrombocytopenia, Hospitalization, Immune thrombocytopenic purpura, Thrombocytopenia.

Abstract

Objective: To determine the severity of thrombocytopenia in pregnancy and manage gestational thrombocytopenia patients in the outpatient department in order to reduce the economic burden on hospitals.

Study Design: Cross-sectional study.

Place and Duration of Study: Department of Haematology, Pakistan Railway Hospital, Rawalpindi, in collaboration with the Departments of Obstetrics and Gynaecology of Combined Military Hospital and Fauji Foundation Hospital, Rawalpindi, Pakistan from Oct 2018 to Oct 2019.

Methodology: The sample population included ninety pregnant females with platelet count <150x109/l. Blood samples were analyzed for complete blood count, peripheral blood smear, manual count by improved Neubauer chamber, serum uric acid, urinary proteins, liver function tests (bilirubin and aspartate aminotransferase), lactate dehydrogenase, coagulation profile and viral serology (hepatitis B & C).

Results: Out of 90 thrombocytopenic pregnant females, gestational thrombocytopenia was most common, (86, 95.5%), while immune thrombocytopenic purpura was detected in 4(4.5%) patients. Mild thrombocytopenia was frequently observed in patients of gestational thrombocytopenia (59, 68.6%), and severe thrombocytopenia was mostly detected in patients of immune thrombocytopenic purpura (3, 75.0%). About 58(64.4%) of these patients were hospitalized, irrespective of the cause of thrombocytopenia.

Conclusion: Mild thrombocytopenia was commonly observed in gestational thrombocytopenia, and severe thrombocytopenia was usually diagnosed in patients with immune thrombocytopenic purpura. Gestational thrombocytopenia is frequent in pregnancy and does not require hospitalization. In contrast, patients with immune thrombocytopenic purpura require rational hospitalization for appropriate and judicious management for the safety of the mother and fetus.

Downloads

Download data is not yet available.

References

Harde M, Bhadade R, deSouza R, Jhingan M. Thrombocytopenia in Pregnancy Nearing Term: A Clinical Analysis. Indian J Crit Care Med 2019; 23(11): 503-508.

https://doi.org/10.5005/jp-journals-10071-23277

Fadiloglu E, Unal C, Tanacan A, Portakal O, Beksac MS. 5 Years' Experience of a Tertiary Center with Thrombocytopenic Pregnancies: Gestational Thrombocytopenia, Idiopathic Thrombocytopenic Purpura and Hypertensive Disorders of Pregnancy. Geburtshilfe Frauenheilkd 2020; 80(1): 76-83.

https://doi.org/10.1055/a-0865-4442

Duletić Načinović A. Trombocitopenija u trudnoći. Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti 2015 ;(42):58-58.

Kasai J, Aoki S, Kamiya N, Hasegawa Y, Kurasawa K, Takahashi T, et al. Clinical features of gestational thrombocytopenia difficult to differentiate from immune thrombocytopenia diagnosed during pregnancy. J Obstet Gynaecol Res 2015 ; 41(1): 44-49.

https://doi.org/10.1111/jog.12496

Kotera K, Kamihira S, de KERCKHOVE C, Kanematsu T, Masuzaki H. A longitudinal, cross-sectional study of diversity in maternal platelet count kinetics, related to gestational thrombocytopenia. Acta Medica Nagasakiensia 2018; 61(3): 117-126.

Wang X, Xu Y, Luo W, Feng H, Luo Y, Wang Y, et al. Thrombocytopenia in pregnancy with different diagnoses: Differential clinical features, treatments, and outcomes. Medicine 2017; 96(29): e7561.

https://doi.org/10.1097/MD.0000000000007561

Grace RF, Neunert C. Second-line therapies in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2016 ; 2016(1): 698-706. https://doi.org/10.1182/asheducation-2016.1.698

Matzdorff A, Meyer O, Ostermann H, Kiefel V, Eberl W, Kühne T, et al. Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI. Oncol Res Treat 2018; 41 Suppl 5: 1-30. https://doi.org/10.1159/000492187

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019; 3(22): 3780-3817.

https://doi.org/10.1182/bloodadvances.2019000812

Ciobanu AM, Colibaba S, Cimpoca B, Peltecu G, Panaitescu AM. Thrombocytopenia in Pregnancy. Maedica 2016; 11(1): 55-60.

Eslick R, McLintock C. Managing ITP and thrombocytopenia in pregnancy. Platelets 2020; 31(3): 300-306.

https://doi.org/10.1080/09537104.2019.1640870

Pishko AM, Levine LD, Cines DB. Thrombocytopenia in pregnancy: Diagnosis and approach to management. Blood Rev. 2020; 40: 100638. https://doi.org/10.1016/j.blre.2019.100638

Handady SOM, Ahmed OII, Mandar OMA. Maternal and Perinatal Outcome Among Pregnant Women with Thrombocytopenia Attending Ibrahim Malik Teaching Hospital-Sudan. WJ Gynecol Women Health 2018;(5):1-4.

https://doi.org/10.33552/WJGWH.2019.01.000522.

Modi K, Chaudhari J, Vaja D. A study of thrombocytopenia in pregnancy. Int J Reproduct Contracept Obstet Gynecol 2020; 9(3): 1116. http://doi.org/10.18203/2320-1770.ijrcog20200885

Fogerty AE, Dzik W. Gestational thrombocytopenia: a case-control study of over 3,500 pregnancies. Br J Haematol 2021; 194(2): 433-438. https://doi.org/10.1111/bjh.17611

McIntosh JJ, Reese J, Deschamps D, Peck J, Vesely S, Terrell D, et al. Defining gestational thrombocytopenia. Am J Obstet Gynecol 2018; 218(1): S50-S1.

Zutshi V, Gupta N, Arora R, Dhanker S. Prevalence of gestational thrombocytopenia and its effect on maternal and fetal outcome. Iraqi J Hematol 2019; 8(1): 21.

https://doi.org/10.4103/ijh.ijh_17_18

Rottenstreich A, Rottenstreich M, Israeli N, Levin G, Elchalal U, Kalish Y, et al Clinical characteristics, neonatal risk and recurrence rate of gestational thrombocytopenia with platelet count< 100X 109/L. Am J Obstet Gynecol 2019; 220(1): S537. https://doi.org/10.1016/j.ajog.2018.11.844

Kong Z, Qin P, Xiao S, Zhou H, Li H, Yang R, et al. A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy. Blood 2017; 130(9): 1097-1103. https://doi.org/10.1182/blood-2017-01-761262

Kim BJ, Kim HS, Kim JH, Lee KY. Moderate to Severe Thrombocytopenia During Pregnancy: A Single Institutional Experience. Indian J Hematol Blood Transfus 2017; 33(4): 581-585. https://doi.org/10.1007/s12288-017-0784-1